Sujata Tyagi Dayal - 07 Nov 2025 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
Director
Signature
/s/ Jessica Perl, Attorney-in-fact
Issuer symbol
EBS
Transactions as of
07 Nov 2025
Net transactions value
-$85,520
Form type
4
Filing time
10 Nov 2025, 16:09:22 UTC
Previous filing
02 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Dayal Sujata Tyagi Director 300 PROFESSIONAL DRIVE, GAITHERSBURG /s/ Jessica Perl, Attorney-in-fact 10 Nov 2025 0001536908

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Sale $85,520 -8,552 -8.8% $10.00 88,980 07 Nov 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on August 8, 2025 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act").
F2 All shares sold at an exact price of $10.00.